 Home > Active Ingredient News > Antitumor Therapy > Polycystic liver disease

Polycystic liver disease

 Last Update: 2022-09-14
 Source: Internet
 Author: User

Tags

congenital liver disease

liver

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

abbreviation

definition

General characteristics

MR performance

Ultrasound performance

Imaging recommended

differential diagnosis

Cysts of the liver (bile ducts).

Biliary hamartomas

Caroli disease

Cystic metastases

pathology

General characteristics

Direct visual pathological features

Microscopic features

Clinical problems

Clinical manifestations

Population distribution characteristics

Natural history and prognosis

treat

Diagnostic points

Focus

Read the main points

：，

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Gefitinib

CAS No.: 184475-35-2

Pharmacy Grade

$1/MT FOB

High quality Sunitinib CAS NO 557795-19-4 Orange solid powder 99% API for antitumor

CAS No.: 557795-19-4

Pharmacy Grade

$4.1-4.2/G FOB

Epirubicin

CAS No.: 56420-45-2

$1/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.